Evaluation of a double-target therapeutic in preclinical models of Parkinson's disease

被引：0
|
作者：
Sanz, F. J.
Solana-Manrique, C.
Masia, E.
Vicent, M. J.
Paricio, N.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
532
引用
收藏
页码：S233 / S233
页数：1
相关论文
共 50 条
  • [21] Sleep and circadian rhythms in Parkinson’s disease and preclinical models
    Jeremy Hunt
    Elizabeth J. Coulson
    Rajendram Rajnarayanan
    Henrik Oster
    Aleksandar Videnovic
    Oliver Rawashdeh
    Molecular Neurodegeneration, 17
  • [22] Therapeutic implications of crocin in Parkinson's disease: A review of preclinical research
    Goyal, Ahsas
    Verma, Aanchal
    Agrawal, Anant
    Dubey, Nandini
    Kumar, Abhay
    Behl, Tapan
    CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 101 (06) : 1229 - 1240
  • [23] Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios
    Hubbard, David
    Hacksell, Uli
    McFarland, Krista
    BEHAVIOURAL PHARMACOLOGY, 2013, 24 (07): : 628 - 632
  • [24] Neuroinflammation in Parkinson's disease and its potential as therapeutic target
    Wang, Qinqin
    Liu, Yingjun
    Zhou, Jiawei
    TRANSLATIONAL NEURODEGENERATION, 2015, 4
  • [25] Axonal regeneration as a therapeutic target toward Parkinson's disease
    Inoue, Haruhisa
    Takahashi, Ryosuke
    Ling, Lin
    Sha, Mi
    Isacson, Ole
    NEUROSCIENCE RESEARCH, 2008, 61 : S7 - S7
  • [26] Potassium Channels: A Potential Therapeutic Target for Parkinson’s Disease
    Xiaoyan Chen
    Bao Xue
    Jun Wang
    Haixia Liu
    Limin Shi
    Junxia Xie
    Neuroscience Bulletin, 2018, 34 : 341 - 348
  • [27] MCL1 as a Therapeutic Target in Parkinson's Disease?
    Robinson, Edward J.
    Aguiar, Sebastian
    Smidt, Marten P.
    Van der Heide, Lars P.
    TRENDS IN MOLECULAR MEDICINE, 2019, 25 (12) : 1056 - 1065
  • [28] Inflammatory gut as a pathologic and therapeutic target in Parkinson's disease
    Lee, Jea-Young
    Wang, Zhen-Jie
    Moscatello, Alexa
    Kingsbury, Chase
    Cozene, Blaise
    Farooq, Jeffrey
    Saft, Madeline
    Sadanandan, Nadia
    Gonzales-Portillo, Bella
    Zhang, Henry
    Esparza Salazar, Felipe
    Lezama Toledo, Alma Rosa
    Rivera Monroy, German
    Berlet, Reed
    Sanberg, Cyndy D.
    Sanberg, Paul R.
    Borlongan, Cesario, V
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [29] Hypoxia Conditioning as a Promising Therapeutic Target in Parkinson's Disease?
    Burtscher, Johannes
    Syed, Muhammed Muazzam Kamil
    Lashuel, Hilal A.
    Millet, Gregoire P.
    MOVEMENT DISORDERS, 2021, 36 (04) : 857 - 861
  • [30] SRY as a potential therapeutic target for men with Parkinson's Disease
    Harley, V.
    MOVEMENT DISORDERS, 2021, 36 : S310 - S310
12345